Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.71784 | 30 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.70126 | 31 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.75492 | 33 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.64513 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.64123 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.74528 | 30 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.72472 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.67775 | 30 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.66797 | 30 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.68228 | 31 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.11806 | 48 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.67074 | 31 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.69549 | 31 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.69265 | 31 |